BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Prion Disease readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Prion Disease\, from 
 ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07832370-11296@assetmemo.bio
DTSTAMP:20261121T004041Z
DTSTART;VALUE=DATE:20310227
DTEND;VALUE=DATE:20310228
SUMMARY:ALN-6457: Phase 1/2 readout est. (NCT07832370)
DESCRIPTION:ALN-6457\, phase 1/2\, Prion Disease.\nStudy: A Trial of ALN-64
 57 in Adult Participants With Symptomatic Prion Disease (PrD)\nEstimated p
 rimary completion: 27 February 2031. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/aln-6457#upcoming-events\nRegistry record: https://clinica
 ltrials.gov/study/NCT07832370
URL:https://assetmemo.bio/drug/aln-6457#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
